Share This Activity
From:
To:
Subject: I'd like to recommend this activity on www.PracticePointCME.com
Message:

HIV

Optimal Management of HIV Disease & Hepatitis: <br />Clinical Conference XXV (OPMAN) – Enduring Video Archive
Certified CME/CE Activity

We are pleased to have recently held the Optimal Management of HIV Disease & Hepatitis: Clinical Conference XXV (OPMAN). The conference took place March 17-19, 2017, in Orlando, Florida with 16 of the leading clinicians and researchers in HIV and hepatitis medicine presenting an array of topics covering HIV disease, hepatitis and HIV-hepatitis B/C coinfection. The presentations offered a unique distillation of clinically focused data tailored for practicing HIV and hepatitis healthcare professionals.

This certified CME/CE enduring video archive of OPMAN XXV provides access to each day of the conference, including the clinical presentations, interactive case discussions and panel discussions addressing audience and faculty questions. CME/CE credit is provided separately by section so you can participate in only those sections of interest to you. We hope you enjoy this activity.
This activity has been approved for 10.5 AMA PRA Category 1 Credits™. Up to 10.5 CNE credits will be awarded for successful completion of these learning activities. Credit/contact hours may be claimed for viewing all links and after completion of each brief Post-test/Evaluation.

  

Jointly provided by the Johns Hopkins University School of Medicine
and the Association of Nurses in AIDS Care







 

MODERATORS

Michael S. Saag, MD
Associate Dean for Global Health, School of Medicine
Director, Center for AIDS Research
University of Alabama at Birmingham
Birmingham, Alabama

Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

FACULTY

Marcus A. Conant, MD
Clinical Professor of Dermatology, Emeritus
University of California, San Francisco Medical Center
San Francisco, California

Kenneth H. Mayer, MD, FACP, FIDSA 
Medical Research Director
Fenway Health
Professor of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts

   

Charles W. Flexner, MD 
Professor of Medicine
Pharmacology and Molecular Sciences, and International Health
Johns Hopkins University
Baltimore, Maryland

Susanna Naggie, MD, MHS
Associate Professor of Medicine
Duke University School of Medicine
Director, Infectious Diseases Research
Duke Clinical Research Institute
Durham, North Carolina

   

Joel E. Gallant, MD, MPH 
Medical Director of Specialty Services
Southwest CARE Center
Santa Fe, New Mexico
Adjunct Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Marion G. Peters, MD 
Professor of Medicine
School of Medicine
University of California, San Francisco
San Francisco, California

   

Rajesh T. Gandhi, MD 
Division of Infectious Disease
Massachusetts General Hospital
Boston, Massachusetts

Wendy D. Post, MD, MS
Professor of Medicine, Division of Cardiology
Johns Hopkins University School of Medicine
Professor of Epidemiology
Bloomberg School of Public Health
Baltimore, Maryland

   

Roy Gulick, MD, MPH 
Rochelle Belfer Professor in Medicine
Chief, Division of Infectious Diseases
Weill Cornell Medicine
Attending Physician, New York Presbyterian Hospital
New York, New York

Kenneth E. Sherman, MD, PhD
Gould Professor of Medicine
Director, Division of Digestive Diseases
University of Cincinnati College of Medicine
Cincinnati, Ohio

   

Kevin P. High, MD, MS  
Professor of Medicine and Translational Science
Executive Vice President
Health Systems Affairs
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina

Glenn J. Treisman, MD, PhD
Eugene Meyer III Professor of Psychiatry and Medicine
Director of AIDS Psychiatry Services
Johns Hopkins School of Medicine
Baltimore, Maryland

   

Arthur Y. Kim, MD 
Associate Professor of Medicine
Harvard Medical School
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

David L. Wyles, MD
Chief, Division of Infectious Diseases
Denver Health
Associate Professor of Medicine
University of Colorado School of Medicine
Denver, Colorado

 


Please review the below required information (use scroll bar on the right)
and then click the
"View Video Archive"
button to access this activity.

INTRODUCTION

This certified CME/CE enduring video archive is designed to educate healthcare providers treating or wishing to treat persons with HIV and/or AIDS, hepatitis, and/or HIV/hepatitis coinfection on the clinical application of the latest scientific data to achieve improved patient outcomes. There are no prerequisites.

Release Date: April 11, 2017
Expiration Date: April 10, 2018

TARGET AUDIENCE

Healthcare providers who treat or wish to treat persons with HIV and/or AIDS, hepatitis, and/or HIV/hepatitis coinfection.

LEARNING OBJECTIVES

After participating in this activity, participants should demonstrate the ability to:

  • Use new information on the pathogenesis of HIV and Viral Hepatitis infection into patient management strategies.
  • Identify antiretroviral and HBV/HCV antiviral therapies based upon the most recent USPHS, IAS-USA, AASLD, IDSA and EASL Guidelines.
  • Manage patients with antiretroviral and/or HBV/HCV therapy failure based upon the most recent data presented at CROI (2017), AASLD (2016), Glasgow (2016), International AIDS Conference (2016), ICAAC (2016), IDSA (2016), and EASL (2016) conferences.
  • Use the latest pharmacogenomics/kinetics/dynamics data in managing antiviral (HIV, HBV, HCV) drug interactions, side effects, and complications of treatment.
  • Evaluate patients for pre-exposure prophylaxis therapy to prevent HIV infection.
  • Identify and manage patient risk factors for cardiovascular complications of HIV and HIV HBV/HCV co-infected patients.

METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT

  • There are no fees for participating in and receiving credit for this activity.
  • Review the activity objectives and CME/CE information.
  • Review all modules associated with this course.
  • Successfully complete the post-test (70% accuracy).
  • Complete the CME/CE evaluation.
  • The estimated time to complete this activity is 10.5 hours.
  • Upon successful completion, your CME/CNE certificate will be available to print for your records.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME/CE activity.

ACCREDITATION STATEMENTS

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Johns Hopkins University School of Medicine and the Association of Nurses in AIDS Care (ANAC). The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
ANAC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

CREDIT DESIGNATION STATEMENTS

Johns Hopkins

PHYSICIANS
The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 10.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACPE

NURSES
The Association of Nurses in AIDS Care (ANAC) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This enduring activity is approved for 10.5 contact hours by the Association of Nurses in AIDS Care.

Participation in the entire knowledge-based activity is required to obtain a certificate. This activity is being presented without bias and with commercial support.

POLICY ON SPEAKER AND PROVIDER DISCLOSURE

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider globally disclose conflicts of interest.  The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.  Detailed disclosure will be made in the instructional materials.

FULL DISCLOSURE POLICY AFFECTING CME/CE ACTIVITIES

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:

FACULTY

The following speakers and/or planners have stated that they have the following financial relationship(s) and they have agreed to see that all information they planned and/or present is done so fairly and without bias:

Marcus A. Conant, MD
Grant/Research Support: None
Consultant: None
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: None

Charles W. Flexner, MD
Grant/Research Support: Gilead Sciences (paid to institution)
Consultant: Cipla, Merck, Mylan Pharmaceuticals, ViiV Healthcare
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: None

Joel E. Gallant, MD, MPH
Grant/Research Support: Bristol-Myers Squibb, Gilead Sciences, Janssen Therapeutics, Merck & Co., ViiV Healthcare/GlaxoSmithKline (all paid to institution)
Consultant: Bristol-Myers Squibb, Gilead Sciences, Janssen Therapeutics, Merck & Co., Inc., ViiV Healthcare/GlaxoSmithKline
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: None

Rajesh T. Gandhi, MD
Grant/Research Support: Gilead Sciences, Merck & Co., ViiV Healthcare (all paid to institution)
Consultant: None
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: None

Roy M. Gulick, MD, MPH
Grant/Research Support: None
Consultant: None
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: None

Kevin High, MD, MS
Grant/Research Support: National Institute on Aging (paid to institution)
Consultant: None
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: Royalties from McGraw-Hill

Arthur Y. Kim, MD
Grant/Research Support: None
Consultant: None
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: None

Kenneth H. Mayer, MD
Grant/Research Support: Gilead Sciences, ViiV Healthcare (paid to institution)
Consultant: None
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: None

Susanna Naggie, MD, MHS
Grant/Research Support: AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen Therapeutics, Merck & Co., Inc., Tacere
Consultant: IDSA, Merck & Co., Inc
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: Educational Activities or Lectures: Clinical Care Option, Eviral Hep, IAS-USA, Mentor Meetings, Platform Q Health Inc, Practice Point Communications, Vindico (paid to institution)

Marion G. Peters, MD
Grant/Research Support: None
Consultant: None
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: Honorarium: Abbott, Genentech, Gilead Sciences, Johnson & Johnson, Merck & Co., Roche

Wendy D. Post, MD
Grant/Research Support: NIH/NHLBI (paid to institution)
Consultant: None
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: None

Kenneth E. Sherman, MD, PhD
Grant/Research Support: AbbVie, Bristol-Myers Squibb, Gilead Sciences, Merck & Co., Innovio, Intercept (paid to institution)
Consultant: MedImmune, ViiV Healthcare
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: None

Glenn J. Treisman, MD, PhD
Grant/Research Support: None
Consultant: None
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: None

David L. Wyles, MD
Grant/Research Support: AbbVie, Gilead Sciences, Merck & Co. (paid to institution)
Consultant – AbbVie, Gilead Sciences, Merck & Co.
Consultant: None
Speakers’ Bureau: None
Stock Shareholder: None
Other Financial or Material Support: None

PLANNING COMMITTEE

Michael Chattergoon, MD, PhD
Grant/Research Support – None
Consultant – None
Speakers’ Bureau – None
Stock Shareholder – None
Other Financial or Material Support – None

Lisa Chester, MBA
Grant/Research Support – None
Consultant – None
Speakers’ Bureau – None
Stock Shareholder – None
Other Financial or Material Support – None

H. Christopher Fleming
Grant/Research Support – None
Consultant – None
Speakers’ Bureau – None
Stock Shareholder – None
Other Financial or Material Support – None

Kelly McCulloch
Grant/Research Support – None
Consultant – None
Speakers’ Bureau – None
Stock Shareholder – None
Other Financial or Material Support – None

Michael S. Saag, MD
Grant/Research Support – AbbVie, Bristol-Myers Squibb, Gilead Sciences, Merck & Co., ViiV Healthcare (paid to institution)
Consultant – Bristol-Myers Squibb, Gilead Sciences, Merck & Co., Teva
Speakers’ Bureau – None
Stock Shareholder – None
Other Financial or Material Support – None

Mark S. Sulkowski, MD
Grant/Research Support – AbbVie, Gilead Sciences, Janssen Therapeutics, Merck & Co., Inc., Tobira (paid to institution)
Consultant – AbbVie, Cocrystal, Gilead Sciences, Janssen Therapeutics, Merck & Co., Inc., Trek Therapeutics
Speakers’ Bureau – None
Stock Shareholder – None
Other Financial or Material Support – Data Safety Monitoring Board: Gilead Sciences (paid to institution)

Allison R. Webel, RN, PhD
Grant/Research Support – None
Consultant – None
Speakers’ Bureau – None
Stock Shareholder – None
Other Financial or Material Support – Honorarium paid to spouse from Gilead Sciences

DISCLAIMER STATEMENT

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own.  This enduring material is produced for educational purposes only.  Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach.  Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

NOTE:

Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

OPINIONS AND OFF-LABEL DISCUSSIONS

In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

CONFIDENTIALITY DISCLAIMER FOR CME/CE ACTIVITY PARTICIPANTS

I certify that I am attending a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am attending in this capacity, I may be exposed to “protected health information,” as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the “Privacy Regulations”). Protected health information is information about a person’s health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g., Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: [email protected]

The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only.

For CME Questions, please contact the CME Office (410) 502-9634 or e-mail [email protected] For CME Certificates, please call (410) 502-9634.

Johns Hopkins University School of Medicine, Office of Continuing Medical Education, Turner 20/720 Rutland Avenue, Baltimore, Maryland 21205-2195 Reviewed & Approved by: General Counsel, Johns Hopkins Medicine (4/1/03) (Updated 4/09 and 3/14)

COPYRIGHT INFORMATION


2017©All rights reserved - The Johns Hopkins University School of Medicine.

Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software (“Materials”) found on the site subject to the following terms, conditions, and exceptions:

The Materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.

Materials may not be published, uploaded, posted, transmitted (other than as set forth herin), without prior written permission.

To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit https://hopkinscme.cloud-cme.com.

HARDWARE/SOFTWARE REQUIREMENTS

Computer:
  • Hardware: A minimum of 512MB of RAM and a Pentium IV CPU for Intel-based hardware & PowerPC G4 or above for MAC.
  • Graphics/Monitor: A color monitor capable of a minimum of 1024 x 768 pixel resolution.
  • Network: An Internet connection with 1Mbps available download & 256kbps bandwidth.
Software/Browser:
  • Windows XP or above running Internet Explorer 7 (service pack 2) or above.
  • MAC OSX 10.5 (Leopard) or above running Safari 5.1 or above, or any version of Chrome, Firefox or Opera published in the last two years.
  • A recent version of a Linux distribution or FreeBSD running Chrome v13, Opera 11.5, Firefox 5.0.1, or Epiphany 3.0.4 or above.
Mobile Device:
  • Any Apple iPad or iPad Mini running iOS 5 or above.
  • Most high-performance Android tablets such as the Kindle Fire or Samsung Galaxy S.

COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported by AbbVie, Bristol-Myers Squibb, Gilead Sciences Medical Affairs, Janssen Therapeutics, Merck & Co, Inc., and ViiV Healthcare


20
Supported by independent educational grants from
AbbVie, Bristol-Myers Squibb, Gilead Sciences Medical Affairs,
Janssen Therapeutics, Merck & Co, Inc., and ViiV Healthcare.
1200
650
April 10, 2018
Mini Module
6137


Upcoming Live Activities


  • Women and HIV: Case Series
    The Boathouse at Rocketts Landing - Richmond, Virginia - Map
    Thursday, June 29, 2017 6:30 PM - Register

  • Clinical Controversies in HIV
    Russell's Steaks, Chops & More - Williamsville, New York - Map
    Monday, July 10, 2017 6:30 PM - Register

  • Lessons Learned: PrEP in Clinical Practice
    Ruth's Chris Steak House - San Diego, California - Map
    Wednesday, July 12, 2017 6:30 PM - Register

  • Living Longer, Living Better with HIV
    Ram's Head Inn - Galloway, New Jersey - Map
    Tuesday, July 18, 2017 6:30 PM - Register

  • Women and HIV: Case Series
    Ruth's Chris Steak House - Pikesville, Maryland - Map
    Wednesday, July 19, 2017 6:30 PM - Register

  • Adolescents and HIV: Guiding and Protecting the Vulnerable
    Ship Lantern Inn - Milton, New York - Map
    Thursday, July 20, 2017 6:00 PM - Register

  • Lessons Learned: PrEP in Clinical Practice
    Morton's The Steakhouse - Houston, Texas - Map
    Thursday, July 27, 2017 6:00 PM - Register

  • Essentials for Optimal HIV Care: Case Series
    Paramount Grill - Gainesville, Florida - Map
    Thursday, August 3, 2017 6:30 PM - Register

  • Lessons Learned: PrEP in Clinical Practice
    Sayaka Japanese Restaurant - Colton, California - Map
    Monday, August 7, 2017 6:30 PM - Register

  • Living Longer, Living Better with HIV
    Fleming's Prime Steakhouse - Palo Alto, California - Map
    Tuesday, August 8, 2017 6:30 PM - Register

  • Essentials for Optimal HIV Care: Case Series
    Bacco Ristorante - Southfield, Michigan - Map
    Wednesday, August 9, 2017 6:30 PM - Register

  • Essentials for Optimal HIV Care: Case Series
    Morton's The Steakhouse - Houston, Texas - Map
    Wednesday, August 23, 2017 6:30 PM - Register

  • Real-World Management of HIV/Hepatitis Coinfection
    Ruth's Chris Steak House - Nashville, Tennessee - Map
    Thursday, August 24, 2017 6:00 PM - Register

  • Post-Conference Update: 9th IAS Conference on HIV Science (IAS 2017) (Available August)
    Vivace - Raleigh, North Carolina - Map
    Tuesday, September 12, 2017 6:00 PM - Register

  • Post-Conference Update: 9th IAS Conference on HIV Science (IAS 2017) (Available August)
    MW Restaurant - Honolulu, Hawaii - Map
    Thursday, September 14, 2017 6:30 PM - Register

  • Post-Conference Update: 9th IAS Conference on HIV Science (IAS 2017) (Available August)
    Marks Prime - Gainesville, Florida - Map
    Thursday, October 5, 2017 6:30 PM - Register

  • Real-World Management of HIV/Hepatitis Coinfection
    Morton's The Steakhouse - Honolulu, Hawaii - Map
    Wednesday, October 18, 2017 6:30 PM - Register

  • Adolescents and HIV: Guiding and Protecting the Vulnerable
    Crowne Plaza - Baton Rouge, Louisiana - Map
    Friday, October 27, 2017 11:15 AM - Register

  • Transgender, Sex Workers and People Who Inject Drugs: Case Series
    Second Empire - Raleigh, North Carolina - Map
    Tuesday, December 5, 2017 6:00 PM - Register

  • Women and HIV: Case Series
    Mark's Prime Steakhouse - Gainesville, Florida - Map
    Thursday, December 7, 2017 6:30 PM - Register
Copyright 2017 by Practice Point Communications